University of Exeter, UK
GP and lead of the DISCOVERY group in Exeter, and clinical lead for the 2015 NICE guidance. Member of the DH’s Policy Research Unit for cancer awareness, screening and early diagnosis. Expertise in risk assessment in primary care diagnostics, and in implementation of cancer innovations.
University of Cambridge, UK
GP and current Chair of the NCRI Primary Care Clinical Studies Group’s Early Diagnosis sub-group, and steering group member of Cambridge Cancer Centre’s Early Detection Programme, with expertise in primary care trials, diagnostic test validation studies, qualitative and mixed methods, and cancer risk assessment.
University of Leeds, UK
GP and Professor of Primary Care Oncology at Leeds; Current Chair of the NCRI Primary Care Clinical Studies Group; Chief Investigator of the WICKED programme (Wales Interventions Cancer Knowledge Early Diagnosis); with expertise in early diagnosis and in primary care trials.
Public health clinician and Cancer Research UK Advanced Clinician Scientist 2015-19, public health physician and cancer healthcare epidemiologist specialising in population studies of variation in cancer diagnostic activity, timeliness and outcomes. Reader in Cancer Epidemiology at UCL.
Durham University, UK
GP and expert in primary care cancer health services research, the Inaugural RCGP/CRUK Clinical Lead for Cancer, and now Clinical Lead for the National Cancer Diagnosis Audit. A senior investigator in the DH-funded Policy Research Unit for Cancer Awareness, Screening and Early Diagnosis. He will chair the CanTest Collaborative Steering Group.
University of Melbourne, AU
GP and inaugural Professor of Primary Care Cancer Research at the Victorian Comprehensive Cancer Centre and Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4). Leads research across the cancer continuum with a focus on the implementation of cancer risk tools and cancer diagnostic tests in primary care.
Baylor College of Medicine, Houston, Texas, US
Chief, Health Policy, Quality & Informatics Program, conducts multidisciplinary research (involving concepts from informatics, social sciences, human factors/psychology and implementation science) on understanding and reducing diagnostic errors, with a major focus in missed and delayed cancer diagnosis. He also focuses on use of health information technology to deliver safe, effective and high-quality care.
University of Washington (UW), Seattle, US
Professor of family medicine focusing on diagnostic testing and innovations, brings expertize in bridging the gap between innovators (commercial and academic) and primary care through directing the UW Primary Care Innovations Lab, at the top ranked primary care department in the USA and a hub of technological innovation. He also brings experience with a new research program on patient centred outcomes of diagnostic tests, and US primary care approaches to cancer screening and diagnostic testing.
University of Aarhus, DK
GP and professor in primary care and innovative health care delivery. He is director of the Research Centre for Cancer Diagnosis in Primary Care (CaP), a cross‐disciplinary research group for primary cancer diagnosis investigating the pathway from symptom to treatment of cancer.
A statistician with particular interests in the use of routine data, variation in cancer diagnostic activity, timeliness and outcomes, and the measurement of patient experience in primary and secondary care.
An experienced health economist specializing in developing methods for health outcome measurement, economic evaluation and economic modelling, across several fiends, including current cancer diagnostic work.
A behavioural scientist with expertise in risk communication and behaviour change, with particular application in primary care, and a member of: NICE Public Health Advisory Committee; DH Policy Research Unit on Behaviour & Health; MRC Scientific Advisory Group for Methodological Research.
Brings expertise in Patient and Public Involvement (PPI) and engagement from inception to delivery of this programme. Margaret will lead a separate PPI stakeholder group with the remit of driving an agenda for proposing areas for study, design and conduct of studies.